Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy

BACKGROUND: Nausea and vomiting of pregnancy (NVP) affects up to 80% of expecting mothers. In April 2013 the FDA approved the delayed-release combination of doxylamine succinate and pyridoxine hydrochloride (Diclegis®) for NVP, based in part, on the results of a phase III randomized trial demonstrat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pregnancy Childbirth
Autors principals: Koren, Gideon, Clark, Shannon, Hankins, Gary D. V., Caritis, Steve N., Umans, Jason G., Miodovnik, Menachem, Mattison, Donald R., Matok, Ilan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122025/
https://ncbi.nlm.nih.gov/pubmed/27881103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12884-016-1172-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars